AMO's Tecnis™ Multifocal Intraocular Lenses (Tecnis MF), Alcon's ReStor Multifocal IOL
1 other identifier
interventional
60
1 country
6
Brief Summary
The purpose of this study is to compare the visual outcomes with bilateral implantation of Tecnis MF and ReSTOR IOLs Six months post cataract surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_4
Started Sep 2010
Typical duration for phase_4
6 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 27, 2010
CompletedStudy Start
First participant enrolled
September 1, 2010
CompletedFirst Posted
Study publicly available on registry
January 17, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2012
CompletedJune 14, 2012
June 1, 2012
2.3 years
August 27, 2010
June 13, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Refraction
1 year
Distance Visual Acuities
1 year
Near Visual Acuities
1 year
Intermediate Acuities
1 year
Study Arms (2)
Tecnis MF
OTHERReSTOR
OTHERInterventions
Eligibility Criteria
You may qualify if:
- Age 18 or greater
- Bilateral condition (cataracts or Presbyopia) for which phacoemulsification and posterior IOL implantation has been planned for both eyes
- Visual potential of 20/25 or better in each eye after cataract removal and IOL implantation
- Clear intraocular media other than cataract
- Normal OCT of the macula
- No evidence of Keratoconus or significant irregular astigmatism on Preoperative topography
- No evidence of Epithelial Basement Membrane Dystrophy on Slit lamp Exam
- Availability, willingness, and sufficient cognitive awareness to comply with examination procedures
You may not qualify if:
- Use of systemic or ocular medications that may affect vision
- Uncontrolled systemic or ocular disease
- History of ocular trauma
- History of intraocular, extraocular Muscle, or corneal surgery (including laser vision correction)
- Amblyopia or strabismus
- Known pathology that may affect visual acuity; particularly retinal changes that affect vision (macular degeneration, cystoid macular edema, proliferative diabetic retinopathy, etc.)
- Diagnosed degenerative visual disorders (e.g. macular degeneration, or other retinal disorders) that are predicted to cause future acuity losses to a level of 20/25 or worse
- Subjects who may be expected to require retinal laser treatment or other surgical intervention (i.e patients with diabetic retinopathy)
- Capsule or zonular abnormalities that may affect postoperative centration or tilt of the lens (e.g. pseudoexfoliation syndrome)
- Contact lens usage within 2 months for PMMA contacts lenses, 2 weeks for gas permeable lenses or 3 days for extended-wear and daily-wear soft contact lenses
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (6)
Sansum- Santa Barbara medical foundation Clinic
Santa Barbara, California, 93101, United States
Katzen Eye Care & Laser Center
Boynton Beach, Florida, 33426, United States
The Center for Excellence in Eye Care
Miami, Florida, 33176, United States
Jackson Eye, SC
Lake Villa, Illinois, 60046, United States
Eye Surgeons of Indiana
Indianapolis, Indiana, 46256, United States
Cleveland Eye Clinic
Breckville, Ohio, 44141, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
William Trattler, MD
The Center for Excellence in Eye Care
- PRINCIPAL INVESTIGATOR
Mitch Jackson, MD
Jackson Eye
- PRINCIPAL INVESTIGATOR
Larry Katzen, MD
Katzen Eye Care & Laser Center
- PRINCIPAL INVESTIGATOR
Kevin Waltz, MD
Eye Surgeons of Indiana
- PRINCIPAL INVESTIGATOR
Shamik Bafna, MD
Clevland Eye Clinic
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
August 27, 2010
First Posted
January 17, 2011
Study Start
September 1, 2010
Primary Completion
December 1, 2012
Study Completion
December 1, 2012
Last Updated
June 14, 2012
Record last verified: 2012-06